MAG
LLY icon

Meadowbrook Advisors Group’s Eli Lilly LLY Stock Holding History

Meadowbrook Advisors Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Sell
567
-142
-20% -$145K 0.36% 75
2026
Q1 		$652K Sell
709
-2
-0.3% -$2.03K 0.39% 68
2025
Q4 		$764K Buy
+711
New +$680K 0.43% 66

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meadowbrook Advisors Group's LLY Position: Q2 2026 in Review

Meadowbrook Advisors Group reduced its Eli Lilly (LLY) stake by 20% in Q2 2026, selling an estimated $145K and leaving 567 shares worth $680K. The position accounts for 0.36% of the portfolio, ranked #75.

Meadowbrook Advisors Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $764K in Q4 2025. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meadowbrook Advisors Group held 567 shares of Eli Lilly worth $680K as of Q2 2026.
  • Meadowbrook Advisors Group sold 142 Eli Lilly shares in Q2 2026, an estimated $145K.
  • Eli Lilly made up 0.36% of Meadowbrook Advisors Group's portfolio in Q2 2026, its #75 holding.
  • Meadowbrook Advisors Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Meadowbrook Advisors Group's Eli Lilly position peaked at $764K in Q4 2025.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meadowbrook Advisors Group's 13F filing for Q2 2026, filed 7 Aug 2026.